A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

Clinical trial NCT06664801 · COMPLETED

Trial details

NCT number: NCT06664801
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2024-11-14
Primary completion: 2025-11-20
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.